Raghav Sehgal and Albert Higgins-Chen’s recent research highlights the variability of biological age clocks, revealing that these metrics can fluctuate significantly even within short time frames. Their study, which evaluated eighteen widely used epigenetic clocks across over 1,000 samples, found that biological age estimates could vary by as much as 5-10 years within a single day, with some clocks showing fluctuations up to 40 years. This raises critical questions about the reliability and stability of these aging biomarkers, which are increasingly used to guide clinical trials and longevity interventions.

The findings underscore the distinction between technical reliability—where repeated measurements of the same sample yield consistent results—and biological reliability, which assesses the consistency of biological age estimates across different time points for the same individual. While many clocks exhibit strong technical reliability, the study revealed that this does not necessarily correlate with biological reliability. This inconsistency poses challenges for interpreting changes in biological age as indicators of therapeutic efficacy or health outcomes, complicating the assessment of interventions aimed at slowing aging.

The implications for longevity research are profound. As the field moves toward integrating biological age clocks into clinical practice, ensuring their reliability must become a priority. The study suggests that a biomarker with lower predictive power but greater stability may ultimately be more valuable than one that is highly predictive yet erratic. Moving forward, researchers must focus on systematically evaluating these clocks across diverse populations and conditions to establish their clinical utility, ensuring that biological age measurements can reliably inform medical decisions and therapeutic development.

Source: longevity.technology